publication venue for
- Asthma, biologics, corticosteroids, and coronavirus disease 2019.. 125:12-13. 2020
- Risk factors for recurrent anaphylaxis-related emergency department visits in the United States.. 121:717-721.e1. 2018
- Understanding caregiver goals, benefits, and acceptable risks of peanut allergy therapies.. 121:575-579. 2018
- Risk factors for severe anaphylaxis in the United States.. 119:356-361.e2. 2017
- Predictors of epinephrine dispensing and allergy follow-up after emergency department visit for anaphylaxis.. 119:452-458.e1. 2017
- Frequency of untreated hypogammaglobulinemia in bronchiectasis.. 119:83-85. 2017
- Cost and health care utilization in patients with asthma and high oral corticosteroid use.. 118:638-639. 2017
- Rate of recurrent anaphylaxis and associated risk factors among Olmsted County, Minnesota, residents: A population-based study.. 117:655-660.e2. 2016
- Anaphylaxis in emergency department patients 50 or 65 years or older.. 106:401-6. 2011
- Prescriptions for self-injectable epinephrine in emergency department angioedema management.. 106:489-93. 2011
- Factors associated with repeated use of epinephrine for the treatment of anaphylaxis.. 103:395-400. 2009